Following our original publication on April 23, 2026, we have had numerous conversations with stakeholders, nephrology practices, industry associations and the Center for Medicare and Medicaid ...

Please provide your email address to receive an email when new articles are posted on . The federal value-based Kidney Care Choices model for kidney disease is now in year 4. Result from year 1 show ...

Researchers have generated induced pluripotent stem cell (iPSC)-derived kidney organoids to model Alport syndrome caused by a mutation in the COL4A5 gene and have demonstrated the utility of a ...

The Centers for Medicare & Medicaid Services (CMS) finalized a six-year mandatory model to increase access to kidney transplants, the agency announced Nov. 26. First proposed in May, the Increasing ...

Kidney organoids generated from human induced pluripotent stem cells (hiPSCs) represent a powerful biological tool that can provide us with a better understanding of the disease mechanism and a means ...

A team developed a human iPS cell-derived kidney organoid-based proximal tubule-on-chip -- OPTECs-on-Chip -- that mimics in vivo renal physiology more closely than ever before. This model exhibits ...

Please provide your email address to receive an email when new articles are posted on . The demonstration project aims to increase kidney transplants by limiting discarded organs and encouraging ...

Research has shown that a kidney transplant improves survival rates and quality of life for the hundreds of thousands of Americans with end-stage renal disease compared to remaining on dialysis.

For the last decade, nephrology practices have navigated kidney care focused Center for Medicare and Medicaid Innovation (“Innovation Center”) models—from ESRD Seamless Care Organizations (“ESCOs”) ...